Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Sep;31(9):e16344.
doi: 10.1111/ene.16344. Epub 2024 May 17.

Co-occurrence of glial fibrillary acidic protein astrocytopathy in a patient with Leber's hereditary optic neuropathy due to DNAJC30 mutations

Affiliations
Case Reports

Co-occurrence of glial fibrillary acidic protein astrocytopathy in a patient with Leber's hereditary optic neuropathy due to DNAJC30 mutations

Maria Pia Giannoccaro et al. Eur J Neurol. 2024 Sep.

Abstract

Leber's hereditary optic neuropathy (LHON) is a mitochondrial disease characterized by visual loss, and rarely associated with extraocular manifestations including multiple sclerosis-like lesions. The association of LHON and neuromyelitis optica spectrum disorders has rarely been reported. Here is reported a case of glial fibrillary acidic protein astrocytopathy presenting with area postrema syndrome in a patient with previously diagnosed recessive LHON due to mutations in the nuclear gene DNAJC30. This case emphasizes the necessity of extensive investigations for other treatable conditions in patients with LHON and otherwise unexplained extraocular involvement and the possibility that also visual symptoms can respond to immune therapy.

Keywords: GFAP antibodies; GFAP astrocytopathy; Leber's hereditary optic neuropathy; NMOSD; area postrema syndrome; neuromyelitis optica.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Figures

FIGURE 1
FIGURE 1
(a) Case timeline. (b) Brain MRI features during the first (A–C) and the second (D–F) episode, showing the presence of a right (A–C) and left (D–F) APS hyperintense lesion in T2 weighted images. APS, area postrema syndrome; CSF, cerebrospinal fluid; ED, emergency department; IVIG, intravenous immunoglobulin; IVMP, intravenous methylprednisolone.

References

    1. Deng B, Wang J, Yu H, et al. Area postrema syndrome in autoimmune glial fibrillary acidic protein astrocytopathy: a case series and literature review. Neurol Neuroimmunol Neuroinflamm. 2022;9(6):e200029. doi:10.1212/NXI.0000000000200029 - DOI - PMC - PubMed
    1. Cleaver J, Morrison H, Reynolds G, James R, Palace J, Chohan G. Late‐onset Leber's hereditary optic neuropathy presenting with longitudinally extensive myelitis harbouring the m.14484T>C mutation: extending the genotype–phenotype spectrum. Mult Scler Relat Disord. 2021;48:102688. doi:10.1016/j.msard.2020.102688 - DOI - PubMed
    1. Stenton SL, Tesarova M, Sheremet NL, et al. DNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome. Brain. 2022;145(5):1624‐1631. doi:10.1093/brain/awac052 - DOI - PMC - PubMed
    1. Riley JS, Tait SW. Mitochondrial dna in inflammation and immunity. EMBO Rep. 2020;21(4):e49799. doi:10.15252/embr.201949799 - DOI - PMC - PubMed
    1. Hanaford A, Johnson SC. The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence. Orphanet J Rare Dis. 2022;17(1):335. doi:10.1186/s13023-022-02495-3 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources